Menü schließen

Blog

2021 should be the year

2021 should be the year when we will finally overcome the Corona pandemic. The medtech industry is optimistic for an economically stable year. A positive factor will be that the first decisions are likely to be taken in Germany on measures that will be funded by the Hospital Future Fund. This is an impetus for

Read more

Medical and healthcare start-ups and clinical research?

Medical and healthcare start-ups and clinical research? As a rule, medical start-ups do not only need the pure effectiveness study and/or risk-benefit assessment of the product for the purpose of their project development. Rather, it is more about receiving real support in order to be really successful with the medical product on the market. German

Read more

Many medical start-ups fail in an early stage.

Many medical start-ups fail in an early stage. But why? In addition to inadequate financing, many difficulties for founders also lie in the lack of demand for the product on the market, in an unproven benefit and in the regulatory requirements. Those companies therefore need special support in the conception and implementation of clinical studies

Read more

Medical device industry under double strain

The medical device industry, which is dominated by medium-sized companies, is currently under double strain: On the one hand, by the financial impact of the Corona pandemic, for example due to postponed operations, and on the other hand, by the completely new legal framework of the EU Medical Devices Regulation (MDR), which will apply from

Read more

Reducing study cycle time

Reducing study cycle times and making research more accessible to patients have been among the biopharmaceutical industry’s most pressing challenges long before the COVID-19 pandemic disrupted business as usual. Companies are focusing on making the study process more efficient and accessible. Research Experts Alliance (REA) has specialised on innovative structures in the field of clinical

Read more

Digital Strategy for Healthcare

“Research and production must continue to be possible for medium-sized medical technology companies in Germany, and must be promoted and even expanded”, says a recent BVMed paper (Initiative MedTech 2030). In order to improve the conditions for research in Germany, every company should be able to deduct ten per cent of its self-financed expenditure on

Read more

Big Wedding Icon says “YES” to PRA

Big Wedding: Icon says “Yes” to PRA. Big Pharma is going bigger and bigger. What do you think about this wedding? Since the last years many big weddings and re-brandings were observed. Services remains still the same: big, bigger, uniform, branched and quite difficult and of course expensive. One might say such weddings are “disruptive”,

Read more

The network for clinical research Research Experts Alliance

The network for clinical research Research Experts Alliance (REA) from Berlin primarily accompanies start-ups and small and medium-sized companies in their medical product development and of course pharmacological studies in all phases of a clinical trial – and beyond.

Big Wedding: Icon says “Yes” to PRA.

Big Pharma is going bigger and bigger. What do you think about this wedding? Since the last years many big weddings and re-brandings were observed. Services remains still the same: big, bigger, uniform, branched and quite difficult and of course expensive. One might say such weddings are “disruptive”, but in fact there is no diversity

Read more

MDR – already ready

The medical technology sector was already ready for the MDR in 2020. However, there are still too few notified bodies that are notified for the MDR. In addition, a large number of official documents for the implementation of the MDR are still not available. As a result, the regulatory system around the MDR is not

Read more